Loading company…
XENOHELIX develops molecular diagnostic technology and kits for diseases associated with microRNA.
XENOHELIX develops molecular diagnostic products for early detection of diseases including cancer and degenerative brain conditions. Its offerings include RNA purification, PCR/qPCR, exosome and alpha-synuclein products, and an ApoE genotyping kit for Alzheimer's disease. Founded in 2019 and based in Incheon, the company received funding from KB Investment and Korea Tech Incubator for Startups in September 2019.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in